Garonit Pharmaceutical Invests $46 Million in New York Facility

Garonit Pharmaceutical, Inc. is set to establish a groundbreaking manufacturing facility in New Windsor, Orange County, New York, which will become the largest producer globally of chlorhexidine gluconate, a critical antiseptic. This strategic move is buoyed by New York state's support, including $3.8 million in public funding and marks a significant advancement in repositioning the state's life sciences and advanced manufacturing sectors. Governor Kathy Hochul's announcement also highlights the state’s commitment to reshoring pharmaceutical manufacturing and strengthening its supply chains. The new facility will create 100 high-caliber jobs, making a substantial contribution to the region's economy and reaffirming New York's status as a leader in life sciences and innovation. With strategic oversight by Empire State Development, Garonit's confidence in New York's robust workforce and infrastructure appears justified, emphasizing long-term economic and innovative growth within the Mid-Hudson region.